269 related articles for article (PubMed ID: 18951085)
1. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.
Carnegie GK; Soughayer J; Smith FD; Pedroja BS; Zhang F; Diviani D; Bristow MR; Kunkel MT; Newton AC; Langeberg LK; Scott JD
Mol Cell; 2008 Oct; 32(2):169-79. PubMed ID: 18951085
[TBL] [Abstract][Full Text] [Related]
2. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
Taglieri DM; Johnson KR; Burmeister BT; Monasky MM; Spindler MJ; DeSantiago J; Banach K; Conklin BR; Carnegie GK
J Mol Cell Cardiol; 2014 Jan; 66():27-40. PubMed ID: 24161911
[TBL] [Abstract][Full Text] [Related]
3. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
Burmeister BT; Taglieri DM; Wang L; Carnegie GK
J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
[TBL] [Abstract][Full Text] [Related]
4. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
5. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex.
Diviani D; Abuin L; Cotecchia S; Pansier L
EMBO J; 2004 Jul; 23(14):2811-20. PubMed ID: 15229649
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5.
He T; Huang J; Chen L; Han G; Stanmore D; Krebs-Haupenthal J; Avkiran M; Hagenmüller M; Backs J
J Mol Cell Cardiol; 2020 Aug; 145():88-98. PubMed ID: 32485181
[TBL] [Abstract][Full Text] [Related]
7. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
Cavin S; Maric D; Diviani D
Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
[TBL] [Abstract][Full Text] [Related]
8. A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy.
del Vescovo CD; Cotecchia S; Diviani D
Mol Cell Biol; 2013 Jan; 33(1):14-27. PubMed ID: 23090968
[TBL] [Abstract][Full Text] [Related]
9. AKAP-Lbc mediates protection against doxorubicin-induced cardiomyocyte toxicity.
Caso S; Maric D; Arambasic M; Cotecchia S; Diviani D
Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2336-2346. PubMed ID: 28923249
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-like protein LC3 regulates the Rho-GEF activity of AKAP-Lbc.
Baisamy L; Cavin S; Jurisch N; Diviani D
J Biol Chem; 2009 Oct; 284(41):28232-28242. PubMed ID: 19696020
[TBL] [Abstract][Full Text] [Related]
11. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
[TBL] [Abstract][Full Text] [Related]
12. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway.
Métrich M; Laurent AC; Breckler M; Duquesnes N; Hmitou I; Courillau D; Blondeau JP; Crozatier B; Lezoualc'h F; Morel E
Cell Signal; 2010 Oct; 22(10):1459-68. PubMed ID: 20576488
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
Dodge-Kafka KL; Gildart M; Li J; Thakur H; Kapiloff MS
J Mol Cell Cardiol; 2018 May; 118():13-25. PubMed ID: 29522762
[TBL] [Abstract][Full Text] [Related]
14. The Rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice.
Mayers CM; Wadell J; McLean K; Venere M; Malik M; Shibata T; Driggers PH; Kino T; Guo XC; Koide H; Gorivodsky M; Grinberg A; Mukhopadhyay M; Abu-Asab M; Westphal H; Segars JH
J Biol Chem; 2010 Apr; 285(16):12344-54. PubMed ID: 20139090
[TBL] [Abstract][Full Text] [Related]
15. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
[TBL] [Abstract][Full Text] [Related]
16. Neurohormonal regulation of cardiac histone deacetylase 5 nuclear localization by phosphorylation-dependent and phosphorylation-independent mechanisms.
Haworth RS; Stathopoulou K; Candasamy AJ; Avkiran M
Circ Res; 2012 Jun; 110(12):1585-95. PubMed ID: 22581927
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy.
Johnson KR; Nicodemus-Johnson J; Spindler MJ; Carnegie GK
PLoS One; 2015; 10(7):e0132474. PubMed ID: 26192751
[TBL] [Abstract][Full Text] [Related]
18. AKAP-Lbc: a molecular scaffold for the integration of cyclic AMP and Rho transduction pathways.
Diviani D; Baisamy L; Appert-Collin A
Eur J Cell Biol; 2006 Jul; 85(7):603-10. PubMed ID: 16460837
[TBL] [Abstract][Full Text] [Related]
19. Nuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells.
Little GH; Bai Y; Williams T; Poizat C
J Biol Chem; 2007 Mar; 282(10):7219-31. PubMed ID: 17179159
[TBL] [Abstract][Full Text] [Related]
20. The in silico identification of small molecules for protein-protein interaction inhibition in AKAP-Lbc-RhoA signaling complex.
Khan A; Munir M; Aiman S; Wadood A; Khan AU
Comput Biol Chem; 2017 Apr; 67():84-91. PubMed ID: 28063348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
